• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞特异性表达 JAK2-V617F 或 CALRmut 可导致骨髓增殖性肿瘤中不同的炎症特征。

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.

机构信息

Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.

Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.

出版信息

J Hematol Oncol. 2024 Jun 9;17(1):43. doi: 10.1186/s13045-024-01562-5.

DOI:10.1186/s13045-024-01562-5
PMID:38853260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11163796/
Abstract

BACKGROUND

Neutrophils play a crucial role in inflammation and in the increased thrombotic risk in myeloproliferative neoplasms (MPNs). We have investigated how neutrophil-specific expression of JAK2-V617F or CALRdel re-programs the functions of neutrophils.

METHODS

Ly6G-Cre JAK2-V617F and Ly6G-Cre CALRdel mice were generated. MPN parameters as blood counts, splenomegaly and bone marrow histology were compared to wild-type mice. Megakaryocyte differentiation was investigated using lineage-negative bone marrow cells upon in vitro incubation with TPO/IL-1β. Cytokine concentrations in serum of mice were determined by Mouse Cytokine Array. IL-1α expression in various hematopoietic cell populations was determined by intracellular FACS analysis. RNA-seq to analyse gene expression of inflammatory cytokines was performed in isolated neutrophils from JAK2-V617F and CALR-mutated mice and patients. Bioenergetics of neutrophils were recorded on a Seahorse extracellular flux analyzer. Cell motility of neutrophils was monitored in vitro (time lapse microscopy), and in vivo (two-photon microscopy) upon creating an inflammatory environment. Cell adhesion to integrins, E-selectin and P-selection was investigated in-vitro. Statistical analysis was carried out using GraphPad Prism. Data are shown as mean ± SEM. Unpaired, two-tailed t-tests were applied.

RESULTS

Strikingly, neutrophil-specific expression of JAK2-V617F, but not CALRdel, was sufficient to induce pro-inflammatory cytokines including IL-1 in serum of mice. RNA-seq analysis in neutrophils from JAK2-V617F mice and patients revealed a distinct inflammatory chemokine signature which was not expressed in CALR-mutant neutrophils. In addition, IL-1 response genes were significantly enriched in neutrophils of JAK2-V617F patients as compared to CALR-mutant patients. Thus, JAK2-V617F positive neutrophils, but not CALR-mutant neutrophils, are pathogenic drivers of inflammation in MPN. In line with this, expression of JAK2-V617F or CALRdel elicited a significant difference in the metabolic phenotype of neutrophils, suggesting a stronger inflammatory activity of JAK2-V617F cells. Furthermore, JAK2-V617F, but not CALRdel, induced a VLA4 integrin-mediated adhesive phenotype in neutrophils. This resulted in reduced neutrophil migration in vitro and in an inflamed vessel. This mechanism may contribute to the increased thrombotic risk of JAK2-V617F patients compared to CALR-mutant individuals.

CONCLUSIONS

Taken together, our findings highlight genotype-specific differences in MPN-neutrophils that have implications for the differential pathophysiology of JAK2-V617F versus CALR-mutant disease.

摘要

背景

中性粒细胞在炎症和骨髓增生性肿瘤(MPN)中血栓形成风险增加中起着至关重要的作用。我们研究了中性粒细胞特异性表达 JAK2-V617F 或 CALRdel 如何重新编程中性粒细胞的功能。

方法

生成了 Ly6G-Cre JAK2-V617F 和 Ly6G-Cre CALRdel 小鼠。与野生型小鼠相比,比较了 MPN 参数,如血细胞计数、脾肿大和骨髓组织学。使用 TPO/IL-1β 在体外孵育时,研究了谱系阴性骨髓细胞中的巨核细胞分化。通过小鼠细胞因子阵列测定小鼠血清中的细胞因子浓度。通过细胞内 FACS 分析确定各种造血细胞群中的 IL-1α 表达。使用从 JAK2-V617F 和 CALR 突变小鼠和患者中分离的中性粒细胞进行 RNA-seq 分析以研究炎症细胞因子的基因表达。使用 Seahorse 细胞外通量分析仪记录中性粒细胞的生物能量。通过在体内(双光子显微镜)和体外(延时显微镜)创建炎症环境来监测中性粒细胞的迁移。在体外(时间 lapse 显微镜)和体内(双光子显微镜)中监测中性粒细胞与整合素、E-选择素和 P-选择素的黏附。使用 GraphPad Prism 进行统计分析。数据表示为平均值±SEM。使用未配对、双尾 t 检验。

结果

令人惊讶的是,中性粒细胞特异性表达 JAK2-V617F,但不是 CALRdel,足以诱导包括小鼠血清中 IL-1 在内的促炎细胞因子。来自 JAK2-V617F 小鼠和患者的中性粒细胞的 RNA-seq 分析揭示了一种独特的炎症趋化因子特征,而在 CALR 突变型中性粒细胞中未表达。此外,与 CALR 突变型患者相比,JAK2-V617F 患者的 IL-1 反应基因显著富集在 JAK2-V617F 阳性中性粒细胞中。因此,JAK2-V617F 阳性中性粒细胞而不是 CALR 突变中性粒细胞是 MPN 中炎症的致病性驱动因素。与此一致的是,表达 JAK2-V617F 或 CALRdel 导致中性粒细胞代谢表型发生显著差异,表明 JAK2-V617F 细胞具有更强的炎症活性。此外,JAK2-V617F 而非 CALRdel 诱导中性粒细胞中 VLA4 整合素介导的黏附表型。这导致体外中性粒细胞迁移减少,并在炎症血管中减少。这种机制可能导致 JAK2-V617F 患者与 CALR 突变个体相比,血栓形成风险增加。

结论

总之,我们的研究结果突出了 MPN 中性粒细胞中的基因型特异性差异,这些差异对 JAK2-V617F 与 CALR 突变疾病的差异病理生理学具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/11fe974b0cba/13045_2024_1562_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/84629e30ea71/13045_2024_1562_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/9f09bb6bdbd6/13045_2024_1562_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/8c27d6c7c438/13045_2024_1562_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/4e647e4cd659/13045_2024_1562_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/861b62039635/13045_2024_1562_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/0e796817f720/13045_2024_1562_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/928d4c5bd7a4/13045_2024_1562_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/708923d98dcb/13045_2024_1562_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/11fe974b0cba/13045_2024_1562_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/84629e30ea71/13045_2024_1562_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/9f09bb6bdbd6/13045_2024_1562_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/8c27d6c7c438/13045_2024_1562_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/4e647e4cd659/13045_2024_1562_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/861b62039635/13045_2024_1562_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/0e796817f720/13045_2024_1562_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/928d4c5bd7a4/13045_2024_1562_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/708923d98dcb/13045_2024_1562_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dc2/11163796/11fe974b0cba/13045_2024_1562_Fig9_HTML.jpg

相似文献

1
Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.中性粒细胞特异性表达 JAK2-V617F 或 CALRmut 可导致骨髓增殖性肿瘤中不同的炎症特征。
J Hematol Oncol. 2024 Jun 9;17(1):43. doi: 10.1186/s13045-024-01562-5.
2
Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms.HLA 基因型对骨髓增殖性肿瘤中突变 CALR 和 JAK2 V617F 驱动的肿瘤发生的差异调节。
Front Immunol. 2024 Sep 16;15:1427810. doi: 10.3389/fimmu.2024.1427810. eCollection 2024.
3
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.JAK2 和 CALR 的激活突变对钙库操纵性钙内流中的细胞内钙流有不同影响。
Cell Commun Signal. 2024 Mar 21;22(1):186. doi: 10.1186/s12964-024-01530-z.
4
CALR mutations screening in wild type JAK2(V617F) and MPL(W515K/L) Brazilian myeloproliferative neoplasm patients.野生型JAK2(V617F)和MPL(W515K/L)巴西骨髓增殖性肿瘤患者的CALR突变筛查
Blood Cells Mol Dis. 2015 Oct;55(3):236-40. doi: 10.1016/j.bcmd.2015.07.005. Epub 2015 Jul 9.
5
Low V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional or Gene Mutations.Ph 阴性慢性骨髓增殖性肿瘤中低 V617F 等位基因负担与其他 或 基因突变相关。
Genes (Basel). 2021 Apr 12;12(4):559. doi: 10.3390/genes12040559.
6
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.骨髓增殖性疾病诊断标准的概念变迁以及骨髓增殖性肿瘤的分子病因学与分类:从1950年的达梅谢克到2005年的万琴克尔及以后
Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7.
7
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.TERT rs2736100 A>C SNP 和 JAK2 46/1 单倍型显著导致 JAK2 V617F 和 CALR 突变的骨髓增殖性肿瘤的发生——一项对 529 例患者的多中心研究。
Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041. Epub 2016 Apr 7.
8
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.在JAK2-V617F阳性骨髓增殖性肿瘤中,Dnmt3a的缺失增加了自我更新能力以及对聚乙二醇干扰素-α的抗性。
Blood. 2024 Jun 13;143(24):2490-2503. doi: 10.1182/blood.2023020270.
9
[Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].[BCR-ABL阴性骨髓增殖性肿瘤中CALR、JAK2和MPL基因突变分析]
Zhonghua Yi Xue Za Zhi. 2015 May 12;95(18):1369-73.
10
Prevalence and phenotypes of V617F and mutations in a Danish general population.在丹麦普通人群中 V617F 和 突变的流行率和表型。
Blood. 2019 Aug 1;134(5):469-479. doi: 10.1182/blood.2019001113. Epub 2019 Jun 19.

引用本文的文献

1
Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cells.整合素信号的激活上调JAK2-V617F阳性造血细胞中的促炎细胞因子。
Cell Commun Signal. 2025 Aug 11;23(1):368. doi: 10.1186/s12964-025-02358-x.
2
Research trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis.2001年至2024年原发性血小板增多症的研究趋势:一项文献计量分析
Discov Oncol. 2025 Apr 15;16(1):528. doi: 10.1007/s12672-025-02232-9.

本文引用的文献

1
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.JAK2 和 CALR 的激活突变对钙库操纵性钙内流中的细胞内钙流有不同影响。
Cell Commun Signal. 2024 Mar 21;22(1):186. doi: 10.1186/s12964-024-01530-z.
2
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.白细胞介素-1β(IL-1β)通过促进 JAK2 突变造血干细胞的早期克隆扩张,促进 MPN 疾病的起始。
Blood Adv. 2024 Mar 12;8(5):1234-1249. doi: 10.1182/bloodadvances.2023011338.
3
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
血小板和中性粒细胞协同作用诱导 JAK2V617F 骨髓增殖性肿瘤中中性粒细胞胞外诱捕网的形成增加。
J Thromb Haemost. 2024 Jan;22(1):172-187. doi: 10.1016/j.jtha.2023.08.028. Epub 2023 Sep 9.
4
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.单细胞多组学鉴定慢性炎症是 TP53 突变型白血病演变的驱动因素。
Nat Genet. 2023 Sep;55(9):1531-1541. doi: 10.1038/s41588-023-01480-1. Epub 2023 Sep 4.
5
Mutations, inflammation and phenotype of myeloproliferative neoplasms.骨髓增殖性肿瘤的突变、炎症与表型
Front Oncol. 2023 May 22;13:1196817. doi: 10.3389/fonc.2023.1196817. eCollection 2023.
6
Calreticulin mutations affect its chaperone function and perturb the glycoproteome.钙网蛋白突变影响其伴侣功能并扰乱糖蛋白组。
Cell Rep. 2022 Nov 22;41(8):111689. doi: 10.1016/j.celrep.2022.111689.
7
Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.抑制白细胞介素-1β可减少 JAK2-V617F 驱动的骨髓增殖性肿瘤小鼠的骨髓纤维化和骨质硬化。
Nat Commun. 2022 Sep 13;13(1):5346. doi: 10.1038/s41467-022-32927-4.
8
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.白细胞介素-1 有助于 JAK2V617F 诱导的骨髓增殖性肿瘤中骨髓纤维化的克隆扩张和进展。
Nat Commun. 2022 Sep 13;13(1):5347. doi: 10.1038/s41467-022-32928-3.
9
β2-Integrins - Regulatory and Executive Bridges in the Signaling Network Controlling Leukocyte Trafficking and Migration.β2-整合素 - 调控白细胞迁移和趋化信号网络中的桥梁。
Front Immunol. 2022 Apr 22;13:809590. doi: 10.3389/fimmu.2022.809590. eCollection 2022.
10
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.I 型而非 II 型钙网织蛋白突变激活未折叠蛋白反应的 IRE1α/XBP1 通路,从而驱动骨髓增殖性肿瘤。
Blood Cancer Discov. 2022 Jul 6;3(4):298-315. doi: 10.1158/2643-3230.BCD-21-0144.